Hawani, Myrna .
HRN: 11-98-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2024
CEFUROXIME 500MG (TAB)
06/16/2024
06/18/2024
PO
500
BID
Acute Pyelonephritis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes